drugset / Trial / NCT02926027
Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
Phase 4
Completed
80 enrolled
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Intermountain Research and Medical Foundation · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons with Elevated Triglycerides (200-499) on Statin Therapy. The study is to determine progression rates of low attenuation plaque under influence of Vascepa as compared to placebo.
Timeline
- Start
- 2017-03-28
- Primary completion
- 2020-05-15
- Completion
- 2020-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | icosapent ethyl | Small molecule | 4 g | Oral |